NBIO

 
Common Stock SEC Reporting - Current
Pink Current Information
Verified Company Profile 3/07/2017
Contact Info
  • 601 21st Street
  • Suite 300
  • Vero Beach, FL 32960

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2016 10-Q
CIK 0001622057
Fiscal Year End 3/31
OTC Marketplace Pink Current
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. 2008
Employees 3 a/o Mar 07, 2017
Company Officers/Contacts
Sean Carrick President
Lowell Holden CFO
Brandon Price SVP, Bus. Dev.
Company Directors
Not Available
Service Providers
Accounting/Auditing Firm
MaloneBailey, LLP
9801 Westheimer Road
Suite 1100
Houston, TX, 77042
United States
 
Securities Counsel
McDowell Odom LLP
28494 Westinghouse Plac
Suite 305
Valencia, CA, 91355
United States
 
Poole & Shaffery LLP
25350 Magic Mountain Parkway
Santa Clarita, CA, 91355
United States
 
Investor Relations Firm

Not Available
Company History
  • Formerly=Jin-En International Group Holding Co. until 9-2014
NBIO Security Details
Share Structure
Market Value1 $6,973,004 a/o Mar 24, 2017
Authorized Shares 100,000,000 a/o Mar 07, 2017
Outstanding Shares 23,013,214 a/o Mar 07, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 5,056,710 a/o Mar 07, 2017
Par Value 0.001
Transfer Agent(s)
Transfer Online, Inc.
Shareholders
Shareholders of Record 125 a/o Mar 07, 2017
Short Selling Data
Short Interest 0 (-100%)
Jan 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security